Maria Cappello

Adalimumab in active ulcerative colitis: A “real-life” observational study

Alessandro Armuzzi, Livia Biancone, Marco Daperno et al. · Digestive and Liver Disease · 2013 · 81 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Immunology +5

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Rita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi et al. · Journal of Crohn s and Colitis · 2014 · 60 citations · Full text

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy

Alessandro Armuzzi, Gionata Fiorino, Angela Variola et al. · Inflammatory Bowel Diseases · 2018 · 56 citations · Full text

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

Livia Biancone, Vito Annese, Sandro Ardizzone et al. · Digestive and Liver Disease · 2017 · 54 citations · Full text

Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder, Clinical Epidemiology +7

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

Sara Onali, Daniela Pugliese, Flavio Caprioli et al. · The American Journal of Gastroenterology · 2022 · 46 citations · Full text